Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Enthusiast Gaming Holdings Inc. - Common Stock
Mesa Air Group, Inc. - Common Stock
Werewolf Therapeutics, Inc. - Common Stock
Edit Watchlist
Top Indices
NASDAQ Composite
Standard & Poors 500
My Portfolio
Articles published by Ambros Therapeutics, Inc.
Ambros Therapeutics Announces Planned Interim Analysis of Phase 3 Clinical Trial Following FDA Feedback
October 26, 2026
From
Ambros Therapeutics, Inc.
Via
GlobeNewswire
Ambros Therapeutics Announces Appointments of John C. Jacobs and Scott Robertson to Board of Directors
August 27, 2026
From
Ambros Therapeutics, Inc.
Via
GlobeNewswire
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement
August 21, 2026
From
Ambros Therapeutics, Inc.
Via
GlobeNewswire
Tickers
HOWL
Ambros Therapeutics Appoints Cris Calsada as Chief Financial Officer and Claire Padgett, Ph.D., as SVP of Clinical Operations and Program Management
June 11, 2026
From
Ambros Therapeutics, Inc.
Via
GlobeNewswire
Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1
June 08, 2026
From
Ambros Therapeutics, Inc.
Via
GlobeNewswire
Ambros Therapeutics Announces Notice of Allowance for New U.S. Patent Application Covering Neridronate for Complex Regional Pain Syndrome Type 1
March 31, 2026
From
Ambros Therapeutics, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.